Patents Represented by Attorney, Agent or Law Firm McDonald Boehnen Hulbert & Berghoff
  • Patent number: 8187233
    Abstract: The present invention relates to a medication delivery device, to dosing mechanisms suitable for use in medication delivery devices, in particular in pen-type injectors, preferably having dose setting means and a drive device enabling the administration of a medicinal product from a single- or multi-dose medication cartridge, to a use of such device, and to a method of manufacturing or assembling such device.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: May 29, 2012
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Michael Harms, Steffen Raab, Dominic George Webber, James Robert Howarth, Trevor John Beckett, Geoffrey Philip Gray, John David Cross
  • Patent number: 7282346
    Abstract: The invention provides methods for prognosis, diagnosis, staging and disease progression in human cancer patients related to expression levels of a variety of immunohistochemical and genetic markers associated with poor cancer prognosis, and in particular those markers related to tumor invasiveness, metastasis and spread. The invention also provides methods using a predictive index for prognosis of cancer patients for metastasis, recurrence and relapse of neoplastic disease. The methods of the invention are useful for making clinical decisions on cancer treatment, surveillance and surgical intervention.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: October 16, 2007
    Assignee: Oncotech, Inc.
    Inventor: John Fruehauf
  • Patent number: 6537972
    Abstract: The present invention relates to the identification of a number of human genes as cellular targets for the design of therapeutic agents for suppressing human immunodeficiency virus infection. These genes encode products which appear to be necessary for HIV replication, as evidenced by an inhibition of HIV infection in cells in which the expression of these genes is down-regulated. In addition, the invention also relates to methods for identifying additional cellular genes as therapeutic targets for suppressing HIV infection, and methods of using such cellular genes and their encoded products in screening assays for selecting additional inhibitors of HIV.
    Type: Grant
    Filed: May 29, 1998
    Date of Patent: March 25, 2003
    Assignee: Subsidiary No. 3., Inc.
    Inventors: Tanya A. Holzmayer, Stephen J. Dunn, Andrew Dayn